Drug trafficking-related inadmissibility cases are evaluated at one of the highest levels of scrutiny under U.S. immigration standards.
These decisions are not based solely on the offense. They are based on how risk is assessed, how behavior is interpreted, and whether the applicant has demonstrated long-term stability and separation from prior conduct.
A denial does not mean your case cannot be approved. It means the submission did not meet the required standard.
U.S. Customs and Border Protection evaluates drug trafficking cases as indicators of distribution behavior, not isolated incidents.Adjudicators assess whether the applicant presents an ongoing risk based on patterns, associations, and intent.
Most denials are not caused by the offense alone. They occur because the submission fails to address the risk concerns that CBP is evaluating.
A stronger file is not about more documents. It is about addressing the right concerns in the right way.
For a drug trafficking waiver to be approved, your file must demonstrate:
This is not about saying the right things. It is about proving them with structure and evidence.
These cases must be rebuilt using a structured, risk-based approach aligned with how adjudicators actually make decisions.
We identify credibility gaps, missing mitigation, and structural weaknesses in the original submission.
We evaluate intent, escalation patterns, and long-term conduct.
We document lawful behavior, stability, and separation from prior conduct.
We rebuild the explanation to demonstrate ownership, consistency, and credibility.
We establish sustained lawful conduct over time.
We deliver a complete, adjudicator-aligned waiver file.
This page is for individuals dealing with high-risk inadmissibility related to drug trafficking or distribution.
These cases require precision, structure, and credibility to be approved.
Drug trafficking waivers are among the most complex cases handled in the U.S. immigration system.
They require advanced mitigation strategy, structured documentation, and a fully rebuilt submission.
$10,000 – $40,000+
Yes, but only with an approved I-192 waiver supported by strong mitigation and evidence.
They are denied when risk is not fully addressed, particularly concerns related to behavior, credibility, and long-term stability.
Yes. A denial usually reflects a weak submission, not an impossible case.
High-risk cases require a structured and precise approach. If your waiver has been denied or you are preparing one, the strategy must be correct from the beginning.